190 related articles for article (PubMed ID: 5110012)
1. [Results of a clinical study on the vasodilator 3,7-dimethyl-1-(5-oxo-hexyl)-xanthine (BL 191)].
Lehrach F; Müller R
Arzneimittelforschung; 1971 Aug; 21(8):1171-4. PubMed ID: 5110012
[No Abstract] [Full Text] [Related]
2. [Therapy of peripheral arterial circulation disorders using 3,7-dimethyl-1-(5-oxo-hexyl)-xanthine (BL 191)].
Denck H
Arzneimittelforschung; 1973 Apr; 23(4):571-3. PubMed ID: 4740236
[No Abstract] [Full Text] [Related]
3. [Polygraphic registrations after parenteral administration of 3,7-dimethyl-1-(5-oxo-hexyl)-xanthine (BL 191)].
Jovanović UJ
Arzneimittelforschung; 1972 Jun; 22(6):994-9. PubMed ID: 4559161
[No Abstract] [Full Text] [Related]
4. Trials of 3,7-dimethyl-1-(5-oxohexyl) xanthine (BL 191) in double-blind tests.
Buckert D; Harwart D
Farmaco Prat; 1976 May; 31(5):264-74. PubMed ID: 773679
[No Abstract] [Full Text] [Related]
5. The influence of 3,7-dimethyl-1-(5-oxo-hexyl)-xanthine (pentoxifylline, BL 191) on serum calcium and magnesium levels.
Lossnitzer K; Raptis S; Grebe B; Müller R
Arzneimittelforschung; 1973 Jul; 23(7):938-40. PubMed ID: 4800449
[No Abstract] [Full Text] [Related]
6. [Clinical studies on the effect of hexobendine (Ustimon) on cerebral circulatory disorders].
Prosenz P; Tschabitscher H
Wien Klin Wochenschr; 1965 Dec; 77(48):953-5. PubMed ID: 5331101
[No Abstract] [Full Text] [Related]
7. [Drug therapy of peripheral arterial blood circulation disorders].
Bollinger A
Dtsch Med Wochenschr; 1969 Nov; 94(45):2347-9. PubMed ID: 5346859
[No Abstract] [Full Text] [Related]
8. [Effect of vasodilator agents on oral glucose tolerance and serum insulin in intravenous long-term treatment of blood circulation disorders involving peripheral arteries].
Heidrich H; Schirop T
Verh Dtsch Ges Inn Med; 1975; 81():1496-7. PubMed ID: 818839
[No Abstract] [Full Text] [Related]
9. [When are vasodilator agents effective in arterial occlusive diseases? Plethysmographic measurements in a double blind trial].
Baitsch G; Schäfer M
Med Welt; 1969 Aug; 35():1910-3. PubMed ID: 4897422
[No Abstract] [Full Text] [Related]
10. [Experiences with the new vasotherapeutic drug Trental in dermatology].
Herger R
Fortschr Med; 1972 Aug; 90(24):865-72. PubMed ID: 4639351
[No Abstract] [Full Text] [Related]
11. [Compensation grade of arterial occlusions and action of intravenously administered vasoactive drugs].
Bollinger A; Lüthy E
Helv Med Acta Suppl; 1967 May; 47():128. PubMed ID: 5286297
[No Abstract] [Full Text] [Related]
12. [Toxicity of 3,7-dimethyl-1-(5-oxo-hexyl)-xanthine in animal experiment].
Schultes E; Popendiker K; Doerr BI; Leuschner F
Arzneimittelforschung; 1971 Oct; 21(10):1446-53. PubMed ID: 5171858
[No Abstract] [Full Text] [Related]
13. [Ophthalmological experiences with the xanthine compound BL 191 (author's transl)].
Heinsius E; Flamm P
Med Klin; 1973 Nov; 68(47):1540-8. PubMed ID: 4781096
[No Abstract] [Full Text] [Related]
14. [Pharmacokinetics of 3,7-dimethyl-1-(5-oxo-hexyl)-xanthine (BL 191) in man].
Hinze HJ
Arzneimittelforschung; 1972 Sep; 22(9):1492-5. PubMed ID: 4678611
[No Abstract] [Full Text] [Related]
15. [Clinical experience with bencyclane in the treatment of vascular obliterations in the limbs].
Krakovskij NI; Taranovic VA
Arzneimittelforschung; 1970 Oct; 20(10):Suppl 10a:1435+. PubMed ID: 5536665
[No Abstract] [Full Text] [Related]
16. [Pulmonary function tests on the bronchospasmolytic effect of 3,7-dimethyl-1-(5-oxo-hexyl)-xanthine].
Nolte D
Arzneimittelforschung; 1971 Oct; 21(10):1453-6. PubMed ID: 5171859
[No Abstract] [Full Text] [Related]
17. Vascular diseases: new results with pentoxifylline.
Belcaro G; Cesarone MR; Ippolito E
Angiology; 2002; 53 Suppl 1():1 p following TOC. PubMed ID: 11863316
[No Abstract] [Full Text] [Related]
18. [Ophthalmological use of bencyclane and ophthalmodynamometric recording of its effect on cerebral vessels].
Födö V
Arzneimittelforschung; 1970 Oct; 20(10):Suppl 10a:1450+. PubMed ID: 5536669
[No Abstract] [Full Text] [Related]
19. Proceedings: Pharmacological effects of 3,7-dimethyl-1-(5-oxohexyl)-xanthine (BL 191).
Sakurai M; Kitatani T; Nagato K; Sakaguchi T
Jpn J Pharmacol; 1974; 24(0):s:68. PubMed ID: 4546078
[No Abstract] [Full Text] [Related]
20. [Value of drugs acting on the smooth musculature by direct and indirect routes in therapy of vascular diseases].
Labò G; Pretolani E
Cardiol Prat; 1971 Feb; 22(1):1-9. PubMed ID: 4398064
[No Abstract] [Full Text] [Related]
[Next] [New Search]
